Serum lipoprotein (A)‎ in patients with fibromyalgia syndrome

Abstract EN

Background : fibromyalgia syndrome (FMS) is the most common rheumatic cause of diffuse pain and multiple regional musculoskeletal pain and disability.

Objective : is to assess the contribution of serum lipoprotein (A) in the pathogenesis of FMS patients.

Methods: One hundred twenty two FMS patients were compared with 60 healthy control individuals who were age and sex matched.

All FMS features and criteria are applied for patients and controls ; patients with secondary FMS were excluded.

Serum Lipoprotein (A): [Lp (A)], body mass s.lipid profile was determined for both groups.

Results : there was a statistical significant difference between patients &controls in serum lipoprotein (A) (P = 0.013).

Also there was a statistical significant correlations between serum Lp(A) and FMS patients' Age (r= 0.310, P=0.034) ; but not with : duration (r = -0.222, P = 0.133), BMI (r = 0.128,P = 0.390) and s.lipid profile (p > 0.05) of FMS patients Conclusion : s.lipoprotein (A) may play an important role in pathogenesis of FMS patients.